التفاصيل البيبلوغرافية
| العنوان: |
A growth‐based assay using fluorescent protein emission to screen for S‐adenosylmethionine synthetase inhibitors. |
| المؤلفون: |
Viola, Ronald E., Parungao, Gwenn G., Blumenthal, Robert M. |
| المصدر: |
Drug Development Research; Feb2024, Vol. 85 Issue 1, p1-12, 12p |
| مصطلحات موضوعية: |
FLUORESCENT proteins, CHEMICAL libraries, ADENOSYLMETHIONINE, CRYPTOSPORIDIUM parvum, ENZYME inhibitors, GLUTAMINE synthetase |
| مستخلص: |
The use of cell growth‐based assays to identify inhibitory compounds is straightforward and inexpensive, but is also inherently insensitive and somewhat nonspecific. To overcome these limitations and develop a sensitive, specific cell‐based assay, two different approaches were combined. To address the sensitivity limitation, different fluorescent proteins have been introduced into a bacterial expression system to serve as growth reporters. To overcome the lack of specificity, these protein reporters have been incorporated into a plasmid in which they are paired with different orthologs of an essential target enzyme, in this case l‐methionine S‐adenosyltransferase (MAT, AdoMet synthetase). Screening compounds that serve as specific inhibitors will reduce the growth of only a subset of strains, because these strains are identical, except for which target ortholog they carry. Screening several such strains in parallel not only reveals potential inhibitors but the strains also serve as specificity controls for one another. The present study makes use of an existing Escherichia coli strain that carries a deletion of metK, the gene for MAT. Transformation with these plasmids leads to a complemented strain that no longer requires externally supplied S‐adenosylmethionine for growth, but its growth is now dependent on the activity of the introduced MAT ortholog. The resulting fluorescent strains provide a platform to screen chemical compound libraries and identify species‐selective inhibitors of AdoMet synthetases. A pilot study of several chemical libraries using this platform identified new lead compounds that are ortholog‐selective inhibitors of this enzyme family, some of which target the protozoal human pathogen Cryptosporidium parvum. [ABSTRACT FROM AUTHOR] |
|
Copyright of Drug Development Research is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder